Groundbreaking Study Finds Peanut Allergy Likely Starts In The Gut
Tag: peanut allergy
Study Shows High Costs and Burden of Peanut Allergy
A study of a large U.S. health insurer database reveals the high dollar and health costs for those living with… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
3 in 4 Kids See Benefit From Viaskin Peanut Patch After 3 Years
After three years of using the Viaskin Peanut patch in children ages 4 to 11, more than half (52 percent)… Read more »
Peanut Patch Therapy Led to Big Quality of Life Improvement for Families
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
Editor’s Remarks to FDA Committee on Peanut Allergy Drug
Allergic Living’s Gwen Smith presented the following statement on Sept. 13, 2019 to the FDA’s Allergenic Products Advisory Committee, which was… Read more »
Viaskin Peanut Patch Submitted to FDA for Approval Consideration
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
Longer Trial Increased Level of Tolerance to AR101 Peanut Therapy
By extending the peanut biologic oral immunotherapy known as AR101 by 28 weeks, a new study finds that a majority… Read more »
Twitter Jokes About Food Allergy: the Trouble with Disease Disrespect
On Twitter, I’ve been noticing some food allergy ‘jokes’ popping up on my feed. As a young adult, I can… Read more »